Literature DB >> 22000396

Dengue virus serotype 4, Roraima State, Brazil.

Pablo Oscar Amezaga Acosta, Rodrigo Melo Maito, Fabiana Granja, Joel da Silva Cordeiro, Thalita Siqueira, Mayara Nunes Cardoso, Andre de Lima Corado, Raphaela Honorato Barletta-Naveca, Felipe Gomes Naveca.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22000396      PMCID: PMC3310685          DOI: 10.3201/eid1710.110776

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Temporão et al. recently reported the detection and characterization of dengue virus serotype 4 (DENV-4) in Boa Vista, Roraima, Brazil (). To date, 4 subtypes of DENV-4 have been recognized: genotype I, which comprises Asian strains (e.g., Thailand-1978-U18441); genotype II, which has been detected since the early 1980s in the Americas (e.g., Brazil-1982-U18425); genotype III, which comprises recently emerged Thai strains (GenBank accession no. AY618989); and genotype IV, which comprises sylvatic strains (GenBank accession no. EF457906) (). Temporão et al. conducted phylogenetic analysis of envelope gene sequences and concluded that 3 samples of DENV from Roraima in 2010 were DENV-4, genotype I (). Unfortunately, the authors mistakenly labeled Asian strains (Thailand-1978 and -1985) as genotype II, and American strains (e.g., Brazil-1982) as genotype I. Those DENV-4 strains isolated in Roraima in 2010 in fact belong to genotype II (,). We had previously analyzed 2 samples isolated from Roraima in 2010 by using C/prM nucleotide sequencing and maximum-likelihood phylogenetic reconstruction. Our results, presented at the XXI National Meeting of Brazilian Society for Virology in October 2010, show that both isolates are indeed genotype II (). Nucleotide sequences are available in GenBank under accession nos. HQ822125 and HQ822126. Temporão et al. also concluded that because only genotype II (reported as genotype I) was identified in their samples, “[it] excludes the possibility that Asian genotypes previously circulated in Brazil.” Beyond its obviously flawed logic, we believe that this statement lacks scientific support; DENV-4 genotype I, closely related to Chinese and Philippine strains, has in fact been shown to occur in the city of Manaus, ≈800 km south of Boa Vista, as reported in 2 recent articles (,). Circulation of DENV-4 genotype I in northern Brazil, probably related to increasingly intense trade with Asian countries, may be sporadic and geographically limited as yet (), but ignoring this evidence can hardly be helpful for dengue surveillance and control. In Response: With regard to their comment on our letter, Dengue Virus Serotype 4, Roraima State, Brazil (), Amézaga Acosta et al. correctly refer to an erroneous correlation between genotype I and American strains and between genotype II and Asian strains (). That was a typographic error in the text and figure. Our Figure shows the correct association.
Figure

Phylogenetic tree demonstrating the 2 clusters of dengue virus serotype 4 correctly associated with corresponding genotypes: genotype II, American strains, including strains isolated in Roraima in 2010; and genotype I, 2 Asian strains. Boldface indicates strains isolated in Roraima. Scale bar indicates 1% nucleotide sequence divergence.

Phylogenetic tree demonstrating the 2 clusters of dengue virus serotype 4 correctly associated with corresponding genotypes: genotype II, American strains, including strains isolated in Roraima in 2010; and genotype I, 2 Asian strains. Boldface indicates strains isolated in Roraima. Scale bar indicates 1% nucleotide sequence divergence. Amézaga Acosta et al. also suggested a scientific inconsistency, that our results exclude circulation of previous Asian strains in Brazil, and argue that Figueiredo et al. () published a letter on the introduction of DENV-4 in Manaus. However, Amézaga Acosta et al. probably do not know that the article by Figueiredo et al. has been contested by the Brazilian Ministry of Health for failing to demonstrate any irrefutable scientific result, including the virus isolation. Our statement was logically based on strong epidemiologic surveillance, virus isolation, serologic evidence (hemagglutination inhibition assay and immunoglobulin ELISA), and clinical aspects. Regarding circulation of 2 genotypes in Brazil, when the article was written, epidemiologic and molecular evidence supported the hypothesis of circulation of only the American genotype (II) in northern Brazil and not the Asian (I) and American (II) genotypes at the same time (,,). More specifically to the Manaus finding, no virus was isolated and no strong serologic evidence (in the lack of virus isolation) was provided, and the Ministry of Health considers this article a mistake, probably caused by laboratory contamination with Asian genotype I. Possible introduction and detection of Asian DENV-4 strains in Brazil should not be ignored because the possibility of multiple introduction events in the country resulting from intense transit of people and commercial activities across Brazil from the Caribbean and Asian regions poses a real risk. However, at this time, only genotype II has been isolated and genetically characterized (). The previously published articles lack strong and reliable scientific evidence.
  5 in total

Review 1.  The history and evolution of human dengue emergence.

Authors:  Nikos Vasilakis; Scott C Weaver
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

2.  Dengue virus serotype 4, Roraima State, Brazil.

Authors:  Pablo Oscar Amezaga Acosta; Rodrigo Melo Maito; Fabiana Granja; Joel da Silva Cordeiro; Thalita Siqueira; Mayara Nunes Cardoso; Andre de Lima Corado; Raphaela Honorato Barletta-Naveca; Felipe Gomes Naveca
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

3.  Dengue virus serotype 4, Roraima State, Brazil.

Authors:  José Gomes Temporao; Gerson Oliveira Penna; Eduardo Hage Carmo; Giovanini Evelim Coelho; Raimunda do Socorro Silva Azevedo; Marcio Roberto Teixeira Nunes; Pedro Fernando da Costa Vasconcelos
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

4.  Dengue virus type 4, Manaus, Brazil.

Authors:  Regina Maria Pinto de Figueiredo; Felipe Gomes Naveca; Michele de Souza Bastos; Miriam do Nascimento Melo; Suziane de Souza Viana; Maria Paula Gomes Mourão; Cristóvão Alves Costa; Izeni Pires Farias
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

5.  Introduction of dengue virus 4 (DENV-4) genotype I into Brazil from Asia?

Authors:  Fernando Lucas de Melo; Camila Malta Romano; Paolo Marinho de Andrade Zanotto
Journal:  PLoS Negl Trop Dis       Date:  2009-04-28
  5 in total
  8 in total

1.  Genetic characterization of dengue virus 4 complete genomes from East Java, Indonesia.

Authors:  Puspa Wardhani; Benediktus Yohan; Mayfanny Tanzilia; Eka Putri Sunari; Billy J Wrahatnala; Faradila K N Hakim; Ali Rohman; Dominicus Husada; Rahma F Hayati; Marsha S Santoso; Justus T O Sievers; A Aryati; R Tedjo Sasmono
Journal:  Virus Genes       Date:  2022-10-20       Impact factor: 2.198

2.  Dengue virus serotype 4, Roraima State, Brazil.

Authors:  Pablo Oscar Amezaga Acosta; Rodrigo Melo Maito; Fabiana Granja; Joel da Silva Cordeiro; Thalita Siqueira; Mayara Nunes Cardoso; Andre de Lima Corado; Raphaela Honorato Barletta-Naveca; Felipe Gomes Naveca
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

3.  Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region.

Authors:  Manoela Heringer; Thiara Manuele A Souza; Monique da Rocha Q Lima; Priscila Conrado G Nunes; Nieli Rodrigues da C Faria; Fernanda de Bruycker-Nogueira; Thaís Chouin-Carneiro; Rita Maria R Nogueira; Flavia Barreto Dos Santos
Journal:  BMC Infect Dis       Date:  2017-06-09       Impact factor: 3.090

4.  Genomic and epidemiological characterisation of a dengue virus outbreak among blood donors in Brazil.

Authors:  Nuno R Faria; Antonio Charlys da Costa; José Lourenço; Paula Loureiro; Maria Esther Lopes; Roberto Ribeiro; Cecilia Salete Alencar; Moritz U G Kraemer; Christian J Villabona-Arenas; Chieh-Hsi Wu; Julien Thézé; Kamran Khan; Shannon E Brent; Camila Romano; Eric Delwart; Brian Custer; Michael P Busch; Oliver G Pybus; Ester C Sabino
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

5.  Detection of DENV-4 genotype I from mosquitoes collected in the city of Manaus, Brazil.

Authors:  Mario Luis Garcia de Figueiredo; Helda L Alfonso; Alberto Anastacio Amarilla; Luiz Tadeu Moraes Figueiredo; Victor Hugo Aquino; Cristóvão Alves da Costa; Sergio Luiz Bessa Luz
Journal:  Virol J       Date:  2013-02-19       Impact factor: 4.099

6.  Fatal outcome of infection by dengue 4 in a patient with thrombocytopenic purpura as a comorbid condition in Brazil.

Authors:  Frederico Figueiredo Amâncio; Maira Alves Pereira; Felipe Campos de Melo Iani; Lorena D'anunciação; Jorge Luís Carvalho de Almeida; Janer Aparecida Silveira Soares; Marcela Lencine Ferraz; Thiago Cardoso Vale; José Roberto Lambertucci; Mariângela Carneiro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 May-Jun       Impact factor: 1.846

7.  False-negative dengue cases in Roraima, Brazil: an approach regarding the high number of negative results by NS1 ag kits.

Authors:  Pablo O A Acosta; Fabiana Granja; Cátia A Meneses; Ismael A S Nascimento; Débora D Sousa; Wilson P Lima Júnior; Felipe Gomes Naveca
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Sep-Oct       Impact factor: 1.846

8.  Isolation of dengue virus serotype 4 genotype II from a patient with high viral load and a mixed Th1/Th17 inflammatory cytokine profile in South Brazil.

Authors:  Diogo Kuczera; Lorena Bavia; Ana Luiza Pamplona Mosimann; Andrea Cristine Koishi; Giovanny Augusto Camacho Antevere Mazzarotto; Mateus Nóbrega Aoki; Ana Maria Ferrari Mansano; Ediléia Inês Tomeleri; Wilson Liuti Costa Junior; Milena Menegazzo Miranda; Maria Lo Sarzi; Wander Rogério Pavanelli; Ivete Conchon-Costa; Claudia Nunes Duarte Dos Santos; Juliano Bordignon
Journal:  Virol J       Date:  2016-06-06       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.